HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation
Maria Serena Roca(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Alfredo Budillon(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale")
Cited by 42
Related Papers
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
|Endocrine Related Cancer|2006|131
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
|Journal of Experimental & Clinical Cancer Research|2019|125
Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells
|Cell Death and Disease|2013|63
Vorinostat synergises with capecitabine through upregulation of thymidine phosphorylase
|British Journal of Cancer|2010|49